Form 4: Director Jiny Kim Acquires 22,000 Stock Options in Cytosorbents Corp

Director Jiny Kim reports the acquisition of 22,000 stock options in Cytosorbents Corp on April 2, 2024, according to a Form 4 filing.

Summary

• On April 2, 2024, Jiny Kim, a director of Cytosorbents Corp, acquired 22,000 stock options.
• The stock options have an exercise price of $0.955.
• These options were granted under the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan.
• The options vest in four equal quarterly installments over one year, contingent upon continued service.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to stock option grants, which is a common practice.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders, incentivizing performance and company growth.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment of interests and assess management's confidence in the company's future prospects.

Stakeholder Impact

• The stock option grant could potentially motivate the director to work towards increasing shareholder value.

Key Dates